Proliferation of cardiomyocytes: A question unresolved

Frontiers in Bioscience - Elite

Volumn 1 E, Issue 2, 2009, Pages 528-536

  De Falco, Maria ^a   Cobellis, Gilda ^b   De Luca, Antonio ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiomyocyte; Cell cycle; Differentiation; Proliferation; Review

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; CELL CYCLE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HEART; HEART MUSCLE CELL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADULT; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 77950912391     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Engel F. B., M. Schebesta, M. T. Duong, G. Lu, S. Ren, J. B. Madwed, H. Jiang, Y. Wang, M. T. Keating: p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19, 1175-1187 (2005) (Pubitemid 40696184)
2. Ahuja P., P. Sdek, W. R. Maclellan: Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration. Physiol. Rev. 87, 521-544 (2007) (Pubitemid 47086282)
3. Anversa P., A. Leri, J. Kajstura: Cardiac regeneration. J. Am. Coll. Cardiol. 47, 1769-1776 (2006)
4. Anversa P., G. Olivetti: Cellular basis of physiologic and pathologic myocardial growth. New York, NY: Oxford University Press, 2001. In: Page E, Fozzard HA, Solaro RJ, editors. Handbook of Physiology; Vol. I: The Cardiovascular System; Section 2: The Heart.: 75-144.
5. Nadal-Ginard B., J. Kajstura, A. Leri, P. Anversa: Myocyte Death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92, 139-150 (2003) (Pubitemid 36254270)
6. Chien K. R., E. N. Olson: Converging pathways and principles in heart development and disease. Cell 110, 153-162 (2002) (Pubitemid 34876544)
7. Olivetti G., R. Ricci, P. Anversa: Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J. Clin. Invest. 80, 1818-1822 (1987)
8. Anversa P., T. Palackal, G. Olivetti, J. M. Papasso: Hypertensive cardiomyopathy: myocyte nuclei hyperplasia in the mammalian heart. J. Clin. Invest. 85, 994-997 (1990) (Pubitemid 20123738)
9. Olivetti G., M. Melissari, T. Balbi, F. Quaini, E. H. Sonnenblick, P. Anversa: Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J. Am. Coll. Cardiol. 24, 140-149 (1994) (Pubitemid 24202789)
10. Quaini F., E. Cigola, C. Lagrasta, G. Saccani, E. Quaini, C. Rossi, G. Olivetti, P. Anversa: End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ. Res. 75, 1050-1063 (1994) (Pubitemid 24351450)
11. Kajstura J., B. Pertoldi, A. Leri, C. A. Beltrami, A. Deptala, Z. Darzynkiewicz, P. Anversa: Telomere shortening is an in vivo marker of myocyte replication and aging. Am. J. Pathol. 156, 813-819 (2000) (Pubitemid 30626939)
12. Takahashi T., H. Schunkert, S. Isoyama, J. Y. Wei, B. Nadal-Ginard, W. Grossman, S. Izumo: Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J. Clin. Invest. 89, 939-946 (1992)
13. Nemer M., M. E. Horb: The KLF family of transcriptional regulators in cardiomyocyte proliferation and differentiation. Cell cycle 6, 117-121 (2007) (Pubitemid 46232486)
14. Engel F. B.: Cardiomyocyte proliferation: A platform for mammalian cardiac repair. Cell Cycle 4, 1360-1363 (2005) (Pubitemid 41437122)
15. Soonpaa M. H., K. K. Kim, L. Pajak, M. Franklin, L. J. Field: Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. Heart Circ. Physiol. 271, H2183-H2189 (1996)
16. Olivetti G., E. Cigola, R. Maestri, D. Corradi, C. Lagrasta, S. R. Gambert, P. Anversa: Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J. Mol. Cell. Cardiol. 28, 1463-1477 (1996) (Pubitemid 26340901)
17. Schmid G., P. Pfitzer: Mitoses and binucleated cells in perinatal human hearts. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 48, 59-67 (1985) (Pubitemid 15169016)
18. Wang J., B. Nadal-Ginard: Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206, 82-88 (1995)
19. Walsh K., H. Perlman: Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7, 597-602 (1997) (Pubitemid 27491422)
20. Koh K. N., M. J. Kang, A. Frith-Terhune, S. K. Park, I. Kim, C. O. Lee, G. Y. Koh: Persistent and heterogeneous expression of the cyclin dependent kinase inhibitor, p27KIP1, in rat hearts during development. J. Mol. Cell. Cardiol. 30, 463-474 (1998) (Pubitemid 28132726)
21. Poolman R. A., R. Gilchrist, G. Brooks: Cell cycle profiles and expressions of p21CIP1 and P27KIP1 during myocyte development. Int. J. Cardiol. 67, 133-142 (1998) (Pubitemid 29029936)
22. Pasumarthi K. B., L. J. Field: Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044-1054 (2002) (Pubitemid 34627902)
23. Studzinski G. P., L. E. Harrison: Differentiationrelated changes in the cell cycle traverse. Int. Rev. Cytol. 189, 1-58 (1999) (Pubitemid 29196962)
24. Sen A., P. Dunnmon, S. A. Henderson, R. D. Gerard, KR. Chien: Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J. Biol. Chem. 263, 19132-19136 (1988) (Pubitemid 19016380)
25. Jackson T., M. F. Allard, C. M. Sreenan, L. K. Doss, S. P. Bishop, J. L. Swain: The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol. Cell. Biol. 10, 3709-3716 (1990)
26. Katz E. B., M. E. Steinhelper, J. B. Delcarpio, A. I. Daud, W. C. Claycomb, L. J. Field: Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am. J. Physiol. Heart Circ. Physiol. 262, H1867-H1876 (1992)
27. Soonpaa M. H., G. Y. Koh, L. Pajak, S. Jing, H. Wang, M. T. Franklin, K. K. Kim, L. J. Field: Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Invest. 99, 2644-2654 (1997) (Pubitemid 27259811)
28. MacLellan W. R., M. D. Schneider: Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62, 289-319 (2000) (Pubitemid 30618265)
29. Tamamori-Adachi M., H. Ito, P. Sumrejkanchanakij, S. Adachi, M. Hiroe, M. Shimizu, J. Kawauchi, M. Sunamori, F. Marumo, S. Kitajima, M. A. Ikeda: Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ. Res. 92, e12-19 (2003)
30. Chaudhry H. W., N. H. Dashoush, H. Tang, L. Zhang, X. Wang, E. X. Wu, D. J. Wolgemuth: Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J. Biol. Chem. 279, 35858-35866 (2004) (Pubitemid 39100593)
31. Sherr C. J.: G1 phase progression: cycling on cue. Cell 79, 551-555 (1994) (Pubitemid 24363798)
32. Nevins J. R.: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429 (1992)
33. Yoshizumi M., W. S. Lee, C. M. Hsieh, J. C. Tsai, J. Li, M. A. Perrella, C. Patterson, W. O. Endege, R. Schlegel, M. E. Lee: Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J. Clin. Invest. 95, 2275-2280 (1995)
34. Brooks G., R. A. Poolman, C. J. McGill, J. M. Li: Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J. Mol. Cell Cardiol. 29, 2261-2271 (1997) (Pubitemid 27348535)
35. Kang M. J., G. Y. Koh: Differential and dramatic changes of cyclin dependent kinase activities in cardiomyocytes during the neonatal period. J. Mol. Cell. Cardiol. 29, 1767-1777 (1997) (Pubitemid 27303083)
36. Flink I. L., S. Oana, N. Maitra, J. J. Bahl, E. Morkin: Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J. Mol. Cell. Cardiol. 30, 563-578 (1998) (Pubitemid 28132734)
37. Kozar K., M. A. Ciemerych, V. I. Rebel, H. Shigematsu, A. Zagozdzon, E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, R. T. Bronson, K. Akashi, P. Sicinski: Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477-491 (2004) (Pubitemid 39485667)
38. Pasumarthi K. B., H. Nakajima, H. O. Nakajima, M. H. Soonpaa, L. J. Field: Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96, 110-118 (2005) (Pubitemid 40095760)
39. Berthet C., K. D. Klarmann, M. B. Hilton, H. C. Suh, J. R. Keller, H. Kiyokawa, P. Kaldis: Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev. Cell. 10, 563-573 (2006)
40. Nakielny S., G. Dreyfuss: Transport of proteins and RNAs in and out of the nucleus. Cell 99, 677-690 (1999) (Pubitemid 30017639)
41. Wente S. R.: Gatekeepers of the nucleus. Science 288, 1374-1377 (2000)
42. Sherr C. J., J. M. Roberts: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999) (Pubitemid 29297917)
43. Cheng M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, C. J. Sherr: The p21 (Cip1) and p27 (Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583 (1999) (Pubitemid 29127070)
44. LaBaer J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, E. Harlow: New functional activities for the p21 family of CDK inhibitors. Genes. Dev. 11, 847-862 (1997) (Pubitemid 27175292)
45. Diehl J. A., F. Zindy, C. J. Sherr: Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957-972 (1997) (Pubitemid 27199876)
46. Diehl J. A., M. Cheng, M. F. Roussel, C. J. Sherr: Glycogen synthase kinase-3 regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511 (1998) (Pubitemid 28553242)
47. Alt J. R., J. L. Cleveland, M. Hannink, J. A. Diehl: Phosphorylation- dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14, 3102-3114 (2000) (Pubitemid 32015129)
48. Germain D., A. Russell, A. Thompson, J. Hendley: Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J. Biol. Chem. 275, 12074-12079 (2000) (Pubitemid 30237782)
49. Akli S., S. Zhan, M. Abdellatif, M. D. Schneider: E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2. Circ. Res. 85, 319-328 (1999) (Pubitemid 29398864)
50. Burton P. B., M. H. Yacoub, P. J. Barton: Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur. Heart J. 20, 604-611 (1999) (Pubitemid 29176683)
51. Krishnamurthy J., C. Torrice, M. R. Ramsey, G. I. Kovalev, K. Al Regaiey, L. Su, N. E. Sharpless: Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299-1307 (2004) (Pubitemid 40385301)
52. Li J. M., G. Brooks: Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 273, H1358-H1367 (1997)
53. Sadoshima J., H. Aoki, S. Izumo: Angiotensin II and serum differentially regulate expression f cyclins, activity of cyclindependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ. Res. 80, 228-241 (1997) (Pubitemid 27056986)
54. Tamamori M., H. Ito, M. Hiroe, Y. Terada, F. Marumo, M. A. Ikeda: Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 275, H2036-H2040 (1998)
55. Classon M., S. Salama, C. Gorka, R. Mulloy, P. Braun, E. Harlow: Combinatorial roles for pRB, p107, p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. USA 97, 10820-10825 (2000)
56. Jiang Z., E. Zacksenhaus, B. L. Gallie, R. A. Phillips: The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14, 1789-1797 (1997) (Pubitemid 27207679)
57. MacLellan W. R., A. Garcia, H. Oh, P. Frenkel, M. C. Jordan, K. P. Roos, M. D. Schneider: Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol. Cell. Biol. 25, 2486-2497 (2005) (Pubitemid 40354641)
58. Cobrinik D.: Pocket proteins and cell cycle control. Oncogene 24, 2796-2809 (2005) (Pubitemid 40638091)
59. Jung J., T. G. Kim, G. E. Lyons, H. R. Kim, Y. Lee: Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein. J. Biol. Chem. 280, 30916-30923 (2005) (Pubitemid 41291823)
60. Kirshenbaum L. A., M. D. Schneider: Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein-and p300-binding domains. J. Biol. Chem. 270, 7791-7794 (1995)
61. Kirshenbaum L. A., M. Abdellatif, S. Chakraborty, M. D. Schneider: Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol. 179, 402-411 (1996) (Pubitemid 26384084)
62. Clarke A. R., E. R. Maandag, M. Van Roon, N. M. Van der Lugt, M. Van der Valk, M. L. Hooper, A. Berns, R. H. Te: Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330 (1992)
63. Jacks T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, R. A. Weinberg: Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992)
64. ELee. Y. H. P., C. Y. Chang, N. Hu, Y. C. J. Wang, C. C. Lai, K. Herrup, W. H. Lee, A. Bradley: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294 (1992)
65. Ashe M., L. Pabon-Pena, E. Dees, K. L. Price, D. Bader: LEK1 is a potential inhibitor of pocket protein-mediated cellular processes. J. Biol. Chem. 279, 664-676 (2004) (Pubitemid 38044871)
66. Cobrinik D., M. H. Lee, G. Hannon, G. Mulligan, R. T. Bronson, N. Dyson, E. Harlow, D. Beach, R. A. Weinberg, T. Jacks: Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644 (1996) (Pubitemid 26268868)
67. Lee M. H., B. O. Williams, G. Mulligan, S. Mukai, R. T. Bronson, N. Dyson, E. Harlow, T. Jacks: Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632 (1996) (Pubitemid 26268867)
68. LeCouter J. E., B. Kablar, P. F. Whyte, C. Ying, M. A. Rudnicki: Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125, 4669-4679 (1998) (Pubitemid 29027197)
69. Liang Q., J. D. Molkentin: Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 35, 1385-1394 (2003) (Pubitemid 37491181)
70. Wang Y., S. Huang, V. P. Sah, J. Ross Jr, J. H. Brown, J. Han, K. R. Chien: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogenactivated protein kinase family. J. Biol. Chem. 273, 2161-2168 (1998) (Pubitemid 28069266)
71. Zarubin T., J. Han: Activation and signaling of the p38 MAP kinase pathway. Cell. Res. 15, 11-18 (2005) (Pubitemid 41653958)
72. Ambrosino C., T. Iwata, C. Scafoglio, M. Mallardo, R. Klein, A. R. Nebreda: TEF-1 and C/EBPbeta are major p38alpha MAPKregulated transcription factors in proliferating cardiomyocytes. Biochem. J. 396, 163-172 (2006) (Pubitemid 43764508)
73. Nebreda A. R., A. Porras: p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25, 257-260 (2000) (Pubitemid 30333380)
74. Ambrosino C., A. R. Nebreda: Cell cycle regulation by p38 MAP kinases. Biol. Cell. 93, 47-51 (2001) (Pubitemid 33040859)
75. D. V. Bulavin, S. A. Amundson, A. J. Fornace: p38 and Chk1 kinases: Different conductors for the G2/M checkpoint symphony. Curr. Opin. Genet. Dev. 12, 92-97 (2002) (Pubitemid 34094996)
76. Shi Y., M. Gaestel: In the cellular garden of forking paths: How p38 MAPKs signal for downstream assistance. Biol. Chem. 383, 1519-1536 (2002) (Pubitemid 35282972)
77. Wu Z., P. J. Woodring, K. S. Bhakta, K. Tamura, F. Wen, J. R. Feramisco, M. Karin, J. Y. Wang, P. L. Puri: p38 and extracellular signalregulated kinases regulate the myogenic program at multiple steps. ol. Cell. Biol. 20, 3951-3964 (2000) (Pubitemid 30314494)
78. Kyriakis J. M., J. Avruch: Mammalian mitogenactivated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869 (2001) (Pubitemid 32267078)
79. Clark A. R., J. L. Dean, J. Saklatvala: Posttranscriptional regulation of gene expression by mitogenactivated protein kinase p38. FEBS Lett. 546, 37-44 (2003) (Pubitemid 36782279)
80. Simone C., S. V. Forcales, D. A. Hill, A. N. Imbalzano, L. Latella, P. L. Puri: p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat. Genet. 36, 738-743 (2004) (Pubitemid 38886636)
81. Germani A., G. Di Rocco, F. Limana, F. Martelli, M. C. Caporossi: Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook. TRENDS Mol. Med. 13, 125-133 (2007) (Pubitemid 46341957)
82. Braz J. C., O. F. Bueno, Q. Liang, B. J. Wilkins, Y. S. Dai, S. Parsons, J. Braunwart, B. J. Glascock, R. Klevitsky, T. F. Kimball, T. E. Hewett, J. D. Molkentin: Targeted inhibition of p38 MAPK promotes ypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Invest. 111, 1475-1486 (2003) (Pubitemid 38063280)